Takuya Tsunoda

9PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 15, 2026
Association of Prior Local Therapy with Outcomes Within Systemic Therapy Regimen Cohorts in Advanced Soft Tissue Sarcoma: A Retrospective Cohort Study.

|Jul 27, 2026
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.

|Dec 30, 2025
Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective Study.

Risako Suzuki, Ryotaro Ohkuma, Makoto Watanabe

|Oct 24, 2025
Increased alanine aminotransferase level as a predictive marker of hand-foot syndrome in patients receiving capecitabine: A retrospective cohort study.

Mei Yamaguchi, Hideki Sugita, Eisuke Inoue

|Jul 29, 2025
Plasma WFDC2 (HE4) as a Predictive Biomarker for Clinical Outcomes in Cancer Patients Receiving Anti-PD-1 Therapy: A Pilot Study.

Makoto Watanabe, Katsuaki Ieguchi, Takashi Shimizu

|Jun 06, 2025
Combination therapy with levofloxacin and the probiotic Clostridium butyricum MIYAIRI 588 enhances immune checkpoint inhibitor efficacy.

Kohei Tajima, Masahiro Hosonuma, Eiji Funayama

Pageof 2

Frequent Collaborators

5 joint publications

Satoshi Wada

3 joint publications

Yutaro Kubota

3 joint publications

Atsushi Horiike

3 joint publications

Masahiro Shimokawa